Stock listing

KRX:196170 Alteogen Inc. (알테오젠) 주가

Follow Alteogen Inc. into a list and get an email when it puts out news.

Share price · KRX:196170

₩211,500 KRW -8,500 (-3.9%)

Close on Oct 30, 2026

Past year -41.7% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
₩208,500 – ₩223,000 KRWOct 30, 2026
Volume
320,978 sharesOct 30, 2026
Market cap
₩14.70T KRWAt the close on Oct 30, 2026 · price × 69.51M shares outstanding
52-week range
₩194,615 – ₩437,692 KRWLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
₩132.5B KRWMedian day 384,694 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Alteogen Inc. logo

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · KRX:196170 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩211,500-8,500-3.9%₩222,500₩223,000₩208,500320,978
₩220,000-3,000-1.3%₩225,000₩226,500₩216,500225,094
₩223,000+4,500+2.1%₩219,500₩228,500₩219,000230,809
₩218,50000.0%₩220,500₩229,500₩217,000224,003
₩218,500-6,000-2.7%₩217,000₩224,500₩216,500155,196
₩224,500-6,500-2.8%₩227,500₩229,000₩220,500229,076
₩231,000-9,000-3.8%₩238,500₩239,000₩229,000168,685
₩240,000+9,000+3.9%₩236,000₩243,500₩235,000248,776
₩231,000-8,000-3.3%₩233,500₩238,000₩226,000205,001
₩239,000+5,000+2.1%₩232,000₩239,000₩229,000264,953
₩234,000+20,500+9.6%₩214,500₩240,500₩214,500546,934
₩213,500-11,000-4.9%₩214,000₩218,000₩209,000392,922
₩224,50000.0%₩223,500₩229,500₩222,000260,527
₩224,500-7,000-3.0%₩220,000₩228,000₩217,500397,458
₩231,500-9,500-3.9%₩238,000₩241,000₩230,000346,024
₩241,000-16,000-6.2%₩239,000₩246,000₩234,500724,009
₩257,000-3,000-1.2%₩265,000₩265,500₩256,500235,563
₩260,000+500+0.2%₩259,000₩266,500₩256,500281,458
₩259,500-5,500-2.1%₩263,500₩268,000₩257,000234,723
₩265,000+10,500+4.1%₩253,500₩266,000₩251,500413,327
₩254,500+1,000+0.4%₩253,500₩259,500₩252,500229,571
₩253,500+1,000+0.4%₩250,000₩255,000₩244,000297,353
₩252,500+2,500+1.0%₩256,500₩260,000₩251,500270,647
₩250,000+500+0.2%₩250,000₩257,500₩248,500222,524
₩249,500-5,500-2.2%₩257,000₩257,500₩248,500276,847
₩255,000+1,500+0.6%₩255,500₩260,000₩253,500193,075
₩253,500-500-0.2%₩256,000₩258,000₩252,500216,543
₩254,000-1,500-0.6%₩258,500₩260,000₩252,000205,493
₩255,500-4,500-1.7%₩258,000₩260,000₩250,500325,625
₩260,00000.0%₩262,000₩267,500₩258,500266,955
₩260,000-8,000-3.0%₩262,000₩263,000₩258,000403,038
₩268,000-9,000-3.2%₩268,000₩271,500₩265,000442,647
₩277,000-2,500-0.9%₩274,500₩279,000₩268,000655,737
₩279,500+2,500+0.9%₩270,000₩280,500₩268,500544,699
₩277,000-9,000-3.1%₩287,500₩287,500₩277,000657,576
₩286,000-2,500-0.9%₩288,500₩290,500₩283,250481,793
₩288,500+5,500+1.9%₩290,500₩294,000₩284,250613,855
₩283,000-15,500-5.2%₩307,000₩313,500₩282,0001,248,714
₩298,500-2,500-0.8%₩293,000₩329,000₩291,0002,219,578
₩301,000-6,500-2.1%₩303,500₩306,000₩297,500281,391
₩307,500-12,500-3.9%₩311,000₩311,000₩293,000656,406
₩320,000+8,500+2.7%₩308,500₩324,500₩305,000615,333
₩311,50000.0%₩306,000₩317,500₩303,500368,961
₩311,500+6,000+2.0%₩305,000₩320,000₩296,500770,565
₩305,500-15,000-4.7%₩310,500₩313,500₩298,500318,030
₩320,500+500+0.2%₩319,000₩324,500₩314,000376,465
₩320,000-19,500-5.7%₩325,000₩328,000₩310,000491,494
₩339,500+36,000+11.9%₩333,000₩344,000₩322,0001,019,594
₩303,500+5,500+1.8%₩295,500₩309,500₩288,000360,184
₩298,000-16,000-5.1%₩310,500₩315,000₩295,500456,936
₩314,000-3,500-1.1%₩317,000₩326,500₩310,000375,775
₩317,50000.0%₩317,500₩322,500₩310,000664,330
₩317,500-10,000-3.1%₩322,500₩325,000₩310,500454,346
₩327,500-20,500-5.9%₩343,000₩350,000₩320,000745,854
₩348,000+43,000+14.1%₩316,000₩356,000₩313,0001,033,262
₩305,000+11,500+3.9%₩290,000₩305,000₩283,000495,569
₩293,500+16,500+6.0%₩284,000₩308,000₩272,000764,630
₩277,000+10,077+3.8%₩289,500₩290,000₩271,000637,092
₩266,923+22,692+9.3%₩243,077₩269,231₩243,077966,632
₩244,231+6,923+2.9%₩233,077₩248,462₩231,923509,828
₩237,308+22,308+10.4%₩223,077₩241,154₩217,692592,041
₩215,000-2,308-1.1%₩210,385₩227,692₩210,385554,208
Ticker
KRX:196170
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

Latest news

Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products

Sep 2, 2026

Closed ₩283,000 (-5.2%) on Sep 3, 2026

Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product

Aug 5, 2026

Closed ₩293,500 (+6.0%) on Aug 6, 2026

Alteogen Showcases ALT-B4's Potential to Transform ADC Development at World ADC Summit 2026

Jun 10, 2026

Closed ₩266,923 (+10.2%) on Jun 11, 2026

Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9)

Sep 17, 2025

Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'

Jul 28, 2025

All Alteogen Inc. news

Decks

Alteogen Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in the last 12 months · 5 in all · newest Sep 2, 2026 · oldest 2025
Decks
3 decks · latest Apr 9, 2026

Log in to ask 6ix AI your own questions about Alteogen Inc.